바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.68 No.4
Citation Share

The Clinical and Pathologic Features according to Expression of Acyl Protein Thioesterase-1 (APT1) in Stage I Non-small Cell Lung Cancer

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2010, v.68 no.4, pp.212-217








& (2010). The Clinical and Pathologic Features according to Expression of Acyl Protein Thioesterase-1 (APT1) in Stage I Non-small Cell Lung Cancer. Tuberculosis & Respiratory Diseases, 68(4), 212-217.
  • Downloaded
  • Viewed
PDF Download

Abstract

Background: Acyl protein thioesterase-1 (APT1) is a cytosolic protein that may function in the depalmitoylation of numerous proteins, including the Ras family. However, the clinical role of depalmitoyl thioesterase in human cancer is not known. We evaluated the APT1 expression in lung cancer tissue and its clinicopathological findings according APT1 expression pattern. Methods: APT1 expression was examined by immunohistochemistry in the tumor tissue from 79 patients, who had undergone curative surgical removal of the primary lesion; all patients had been diagnosed with stage I non-small cell lung cancer between 1993 and 2004, at Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Results: The APT1 expression was seen in 50 out of 79 (63.3%) cases. The positive APT1 expression was significantly related with histologic subtype and T stage, but was not influenced by differentiation. The positive APT1 expression was not significantly related to patient age, gender, or smoking history. The median follow-up duration was 10.0 years; the 5-year survival rate was 71.0%. The positive APT1 expression group showed significantly worse overall survival and worse disease-free survival without statistical significance. Conclusion: We conclude that positive APT1 expression in stage I lung cancer after surgery is closely associated with overall survival. To evaluate APT1 as a prognostic marker in lung cancer, comprehensive studies on advanced stage cases are needed.

keywords
Acyl protein thioesterase, Carcinoma, Non-Small-Cell Lung, Biological Markers

Reference

1.

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ.Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-49.

2.

2. Subotic D, Mandaric D, Radosavljevic G, Stojsic J, Gajic M, Ercegovac M. Relapse in resected lung cancer revisited:does intensified follow up really matter? A prospective study. World J Surg Oncol 2009;7:87.

3.

3. Wang A, Dennis EA. Mammalian lysophospholipases.Biochim Biophys Acta 1999;1439:1-16.

4.

4. Baekkeskov S, Kanaani J. Palmitoylation cycles and regulation of protein function (Review). Mol Membr Biol 2009;26:42-54.

5.

5. Sugimoto H, Hayashi H, Yamashita S. Purification,cDNA cloning, and regulation of lysophospholipase from rat liver. J Biol Chem 1996;271:7705-11.

6.

6. Molina JR, Adjei AA. The Ras/Raf/MAPK Pathway. J Thorac Oncol 2006;1:7-9.

7.

7. Riely GJ, Marks J, Pao W. KRAS Mutations in non-small cell lung cancer. Proc Am Thorac Soc 2009;6:201-5.

8.

8. Quatela SE, Philips MR. Ras signaling on the Golgi.Curr Opin Cell Biol 2006;18:162-7.

9.

9. Chiu VK, Bivona T, Hach A, Sajous JB, Silletti J, Wiener H, et al. Ras signalling on the endoplasmic reticulum and the Golgi. Nat Cell Biol 2002;4:343-50.

10.

10. Johnson L, Mercer K, Greenbaum D, Bronson RT,Crowley D, Tuveson DA, et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001;410:1111-6.

11.

11. Sakuma Y, Matsukuma S, Yoshihara M, Nakamura Y,Noda K, Nakayama H, et al. Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations. Am J Clin Pathol 2007;128:100-8.

12.

12. Marchetti A, Martella C, Felicioni L, Barassi F, Salvatore S, Chella A, et al. EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. J Clin Oncol 2005;23:857-65.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy